{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:52:08Z","timestamp":1793886728310,"version":"4.8.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.rcsop.2024.100494","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:38:18Z","timestamp":1724413098000},"page":"100494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Nonsteroidal anti-inflammatory drug use by patients: Impact of modular educational training on pharmacists' questioning, counselling and risk assessments"],"prefix":"10.1016","volume":"15","author":[{"given":"Segun Johnson","family":"Showande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope Eunice","family":"Akinbode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2024.100494_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00045391-200007020-00008","article-title":"Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, rheumatism, and aging medical information system","volume":"7","author":"Singh","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.rcsop.2024.100494_bb0010","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2165\/00003495-200464230-00001","article-title":"NSAID-related psychiatric adverse events","volume":"64","author":"Onder","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.rcsop.2024.100494_bb0015","article-title":"The fight against rheumatism: from willow bark to COX-1 sparing drugs","volume":"51","author":"Vane","year":"2000","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3126\/jcmc.v6i4.16716","article-title":"Evaluation of prescribing pattern of NSAIDs in south Indian teaching hospital","volume":"6","author":"Kumar","year":"2016","journal-title":"J Chitwan Med Coll"},{"key":"10.1016\/j.rcsop.2024.100494_bb0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0889-8553(05)70219-3","article-title":"Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs. Epidemiologic and economic issues","volume":"30","author":"Straus","year":"2001","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rcsop.2024.100494_bb0030","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1586\/14737175.6.11.1643","article-title":"Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal","volume":"6","author":"Davies","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.rcsop.2024.100494_bb0035","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18433\/J3VW2F","article-title":"Adverse effects of nonsteroidal Antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.rcsop.2024.100494_bb0040","series-title":"Quantifying the Impact of NSAID-Associated Adverse Events","volume":"19","author":"Michael Fine","year":"2013"},{"key":"10.1016\/j.rcsop.2024.100494_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2024.100494_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6904-9-8","article-title":"The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty","volume":"9","author":"Brvar","year":"2009","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11096-009-9310-3","article-title":"Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand","volume":"31","author":"Jarernsiripornkul","year":"2009","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.rcsop.2024.100494_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14740338.2014.939582","article-title":"Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy","volume":"13","author":"Parretta","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100494_bb0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00002018-200831070-00006","article-title":"Influence of regulatory measures on the rate of spontaneous adverse drug reaction reporting in Italy","volume":"31","author":"Motola","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100494_bb0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/14740338.2016.1135127","article-title":"Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand","volume":"15","author":"Patsuree","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100494_bb0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1734-1140(10)70310-8","article-title":"NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population","volume":"62","author":"Capone","year":"2010","journal-title":"Pharmacol Rep PR"},{"issue":"Suppl","key":"10.1016\/j.rcsop.2024.100494_bb0080","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.clinthera.2007.12.003","article-title":"Adverse drug interactions involving common prescription and over-the-counter analgesic agents","volume":"29","author":"Hersh","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.rcsop.2024.100494_bb0085","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00228-014-1734-6","article-title":"Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects","volume":"70","author":"Wehling","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2296-12-70","article-title":"Cause for concern in the use of non-steroidal anti-inflammatory medications in the community -a population-based study","volume":"12","author":"Adams","year":"2011","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0095","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s11096-016-0363-9","article-title":"Knowledge and perceptions of the risks of non-steroidal anti-inflammatory drugs among orthopaedic patients in Thailand","volume":"38","author":"Phueanpinit","year":"2016","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1188\/10.ONF.774-781","article-title":"The influence of easy-to-read pamphlets about self-care management of radiation side effects on patients\u2019 knowledge","volume":"37","author":"Wilson","year":"2010","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.rcsop.2024.100494_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/PPA.S27378","article-title":"Can a feedback report and training session on medication counseling for general practitioners improve patient satisfaction with information on medicines?","volume":"6","author":"Mahler","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.rcsop.2024.100494_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pec.2010.10.032","article-title":"Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients\u2019 risk awareness","volume":"83","author":"Schmitt","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2024.100494_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjoq-2017-000303","article-title":"Implementing a non-steroidal anti-inflammatory drugs communication bundle in remote and rural pharmacies and dispensing practices","volume":"7","author":"Morrison","year":"2018","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.rcsop.2024.100494_bb0120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4314\/tjpr.v7i3.14685","article-title":"The pattern of sale and use of non-steroidal anti-inflammatory drugs in rural and urban centres in Nigeria","volume":"7","author":"Awofisayo","year":"2008","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.rcsop.2024.100494_bb0125","first-page":"25","article-title":"Prescribing pattern of non-steroidal ant-inflammatory drugs at the outpatient pharmacy Department of Lagos University Teaching Hospital, Nigeria, Ghana","volume":"49","author":"Awodele","year":"2015","journal-title":"Medizinhist J"},{"key":"10.1016\/j.rcsop.2024.100494_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/aam.aam_57_19","article-title":"Evaluation of prescription pattern of analgesic use among ambulatory elderly in South-Western Nigeria","volume":"19","author":"Akande-Sholabi","year":"2020","journal-title":"Ann Afr Med"},{"key":"10.1016\/j.rcsop.2024.100494_bb0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1017\/S1463423618000142","article-title":"Evaluation of community pharmacists\u2019 roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand","volume":"19","author":"Phueanpinit","year":"2018","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.rcsop.2024.100494_bb0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1331\/154434504322713192","article-title":"Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness","volume":"44","author":"Svarstad","year":"2004","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2024.100494_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sapharm.2008.08.006","article-title":"A review of counseling practices on prescription medicines in community pharmacies","volume":"5","author":"Puspitasari","year":"2009","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100494_bb0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.312.7031.629","article-title":"Over the counter drugs: patients, society, and the increase in self medication","volume":"312","author":"Blenkinsopp","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2024.100494_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2125.2006.02642.x","article-title":"Patients\u2019 knowledge of adverse reactions to current medications","volume":"62","author":"Cullen","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4140\/TCP.n.2017.161","article-title":"Pharmacist counseling and the use of nonsteroidal anti-inflammatory drugs by older adults","volume":"32","author":"Bear","year":"2017","journal-title":"Consult Pharm"},{"key":"10.1016\/j.rcsop.2024.100494_bb0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s11096-014-0018-7","article-title":"Hospital pharmacists\u2019 roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand","volume":"36","author":"Phueanpinit","year":"2014","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0170","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.pec.2020.09.018","article-title":"Impact of pharmacists\u2019 training on oral anticoagulant counseling: a randomized controlled trial","volume":"104","author":"Showande","year":"2021","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2024.100494_bb0175","first-page":"873","article-title":"Management of musculoskeletal pain in retail drug outlets within a Nigerian community: a descriptive study","author":"Abdu-Aguye","year":"2017","journal-title":"Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0180","first-page":"2218","article-title":"Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs","volume":"32","author":"Wilcox","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.15537\/smj.2020.8.25221","article-title":"Evaluation of the community pharmacists\u2019 performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi Arabia","volume":"41","author":"Malebari","year":"2020","journal-title":"Saudi Med J"},{"key":"10.1016\/j.rcsop.2024.100494_bb0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jep.12806","article-title":"Physicians\u2019 communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients","volume":"23","author":"Phueanpinit","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.2042-7174.1997.tb00887.x","article-title":"\u201cOne simple question should be enough\u201d: consumers\u2019 perceptions of pharmacy protocols","volume":"5","author":"Morris","year":"1997","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/j.2055-2335.2011.tb00102.x","article-title":"Unanswered health-related questions in community pharmacy: frequency, nature and consequences","volume":"41","author":"Gordon","year":"2011","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.rcsop.2024.100494_bb0205","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s11096-019-00905-4","article-title":"Management of uncomplicated gastric ulcer in community pharmacy: a pseudo-patient study","volume":"41","author":"Showande","year":"2019","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1211\/ijpp.16.6.0003","article-title":"Pharmacist-led medication review for knee pain in older adults: content, process and outcomes","volume":"16","author":"Phelan","year":"2008","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/PPA.S436952","article-title":"The effects of pharmacist-led medication therapy management on medication adherence and use of non-steroidal anti-inflammatory drug in patients with pre-end stage renal disease","volume":"18","author":"Wang","year":"2024","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.rcsop.2024.100494_bb0220","first-page":"806","article-title":"Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial","volume":"81","author":"Garcia","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"suppl 1","key":"10.1016\/j.rcsop.2024.100494_bb0225","first-page":"S153","article-title":"Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial","volume":"74","author":"Garcia","year":"1998","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.rcsop.2024.100494_bb0230","first-page":"183","article-title":"A pharmacy based protocol and training program for non-prescription analgesics","volume":"17","author":"Neto","year":"2000","journal-title":"J Soc Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100494_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13643-018-0727-4","article-title":"Interventions for improving pharmacist-led patient counselling in the community setting: a systematic review","volume":"7","author":"Al Aqeel","year":"2018","journal-title":"Syst Rev"},{"key":"10.1016\/j.rcsop.2024.100494_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11096-010-9375-z","article-title":"Use of simulated patients to assess the clinical and communication skills of community pharmacists","volume":"32","author":"Weiss","year":"2010","journal-title":"Pharm World Sci PWS"},{"key":"10.1016\/j.rcsop.2024.100494_bb0245","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11096-011-9605-z","article-title":"Dispensing practice in the community pharmacies in the Turkish republic of northern Cyprus","volume":"34","author":"Gokcekus","year":"2012","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0250","series-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2007"},{"key":"10.1016\/j.rcsop.2024.100494_bb0255","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/tc.4.4.338","article-title":"The sale of nicotine replacement therapies from community pharmacies","volume":"4","author":"Sinclair","year":"1995","journal-title":"Tob Control"},{"key":"10.1016\/j.rcsop.2024.100494_bb0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/fampra\/19.5.529","article-title":"Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT)","volume":"19","author":"Watson","year":"2002","journal-title":"Fam Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12913-022-07535-z","article-title":"Drug therapy-related problem management in Nigeria community pharmacy \u2013 process evaluation with simulated patient","volume":"22","author":"Segun","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rcsop.2024.100494_bb0270","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s11096-014-9982-1","article-title":"Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review","volume":"36","author":"Okumura","year":"2014","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0275","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.pec.2021.08.009","article-title":"Engaging consumers in wise use of over-the-counter medications in Taiwan: development and evaluation of a structured medication counseling approach","volume":"105","author":"Huang","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2024.100494_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pec.2010.04.029","article-title":"Factors predicting poor counselling about prescription medicines in Swedish community pharmacies","volume":"83","author":"Tully","year":"2011","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.rcsop.2024.100494_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ijpp.12152","article-title":"A ustralian pharmacies prevent potential adverse reactions in patients taking warfarin requesting over-the-counter analgesia","volume":"23","author":"MacFarlane","year":"2015","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0290","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1D519","article-title":"Evaluation of community Pharmacists\u2019 recommendations to standardized patient scenarios","volume":"38","author":"Rutter","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rcsop.2024.100494_bb0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40545-022-00502-3","article-title":"Patient medication counselling in community pharmacy: evaluation of the quality and content","volume":"15","author":"Showande","year":"2022","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0300","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.sapharm.2014.09.003","article-title":"Pharmacists thought processes in making a differential diagnosis using a gastro-intestinal case vignette","volume":"11","author":"Akhtar","year":"2015","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.rcsop.2024.100494_bb0305","first-page":"125","article-title":"Decision making by community pharmacists when making an over-the-counter diagnosis in response to a dermatological presentation","volume":"4","author":"Rutter","year":"2013","journal-title":"Self Care"},{"key":"10.1016\/j.rcsop.2024.100494_bb0310","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s12913-023-09642-x","article-title":"Practice of pharmaceutical care by community pharmacists in response to self-medication request for a cough: a simulated client study","volume":"23","author":"Loh","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rcsop.2024.100494_bb0315","first-page":"93","article-title":"Audit of advice provided in response to symptoms","volume":"252","author":"Krska","year":"1994","journal-title":"Pharm J"},{"key":"10.1016\/j.rcsop.2024.100494_bb0320","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.2042-7174.1996.tb00855.x","article-title":"An audit of responding to symptoms in community pharmacy","volume":"4","author":"Krska","year":"2011","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0325","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12913-015-1220-6","article-title":"Counselling practices in community pharmacies in Riyadh, Saudi Arabia: a cross-sectional study","volume":"15","author":"Alaqeel","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.rcsop.2024.100494_bb0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1211\/ijpp.14.2.0002","article-title":"A systematic review of the use of simulated patients and pharmacy practice research","volume":"14","author":"Watson","year":"2006","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0335","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1345\/aph.1P142","article-title":"Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma","volume":"44","author":"Schneider","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rcsop.2024.100494_bb0340","first-page":"918","article-title":"Evaluation of a pharmacist-managed nonsteroidal anti-inflammatory drugs Deprescribing program in an integrated health care system","volume":"26","author":"Rashid","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.rcsop.2024.100494_bb0345","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4103\/jfmpc.jfmpc_201_20","article-title":"NSAIDs and self-medication: a serious concern","volume":"9","author":"Doomra","year":"2020","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.rcsop.2024.100494_bb0350","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jsps.2022.06.011","article-title":"Assessment of Qatar community pharmacists\u2019 competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDs","volume":"30","author":"Owusu","year":"2022","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.rcsop.2024.100494_bb0355","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/14740338.2016.1139571","article-title":"Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand","volume":"15","author":"Jarernsiripornkul","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.rcsop.2024.100494_bb0360","first-page":"597","article-title":"The practice of OTC counseling by community pharmacists in Parana, Brazil","volume":"13","author":"Halila","year":"2015","journal-title":"Pharm Pract"},{"key":"10.1016\/j.rcsop.2024.100494_bb0365","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1345\/aph.1M086","article-title":"Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study","volume":"43","author":"Schneider","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rcsop.2024.100494_bb0370","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11096-011-9482-5","article-title":"How do pharmacists respond to complaints of acute insomnia? A simulated patient study","volume":"33","author":"Kippist","year":"2011","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2024.100494_bb0375","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pec.2015.03.007","article-title":"Patient\u2013provider interaction during medication encounters: a study in outpatient pharmacies in the Netherlands","volume":"98","author":"Koster","year":"2015","journal-title":"Patient Educ Couns"},{"issue":"e52510","key":"10.1016\/j.rcsop.2024.100494_bb0380","doi-asserted-by":"crossref","first-page":"0052510","DOI":"10.1371\/journal.pone.0052510","article-title":"Using the simulated patient methodology to assess paracetamol-related counselling for headache","volume":"7","author":"Horvat","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.rcsop.2024.100494_bb0385","first-page":"149","article-title":"Pharmaceutical care services in hospitals of Kuwait","volume":"9","author":"Awad","year":"2006","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.rcsop.2024.100494_bb0390","author":"Nwafor"},{"key":"10.1016\/j.rcsop.2024.100494_bb0395","article-title":"Multi-national pharmacists needs assessment in the management of anticoagulation therapy: results of the international pharmacist anticoagulation care taskforce (iPACT) survey","volume":"39","author":"Papastergiou","year":"2017","journal-title":"Int J Clin Pharmacol"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662400091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266727662400091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T10:53:27Z","timestamp":1727348007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266727662400091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":79,"alternative-id":["S266727662400091X"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100494","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal anti-inflammatory drug use by patients: Impact of modular educational training on pharmacists' questioning, counselling and risk assessments","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100494"}}